$2.42T
Total marketcap
$72.93B
Total volume
BTC 50.88%     ETH 14.95%
Dominance

Bio-Rad Laboratories, Inc. BUWA.F Stock

285 EUR {{ price }} -6.588006% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
8.17B EUR
LOW - HIGH [24H]
285 - 289.9 EUR
VOLUME [24H]
10 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-20.35 EUR

Bio-Rad Laboratories, Inc. Price Chart

Bio-Rad Laboratories, Inc. BUWA.F Financial and Trading Overview

Bio-Rad Laboratories, Inc. stock price 285 EUR
Previous Close 341 EUR
Open 343 EUR
Bid 343 EUR x 5000
Ask 349.8 EUR x 5000
Day's Range 343 - 343 EUR
52 Week Range 331 - 545.6 EUR
Volume 4 EUR
Avg. Volume 2 EUR
Market Cap 10.05B EUR
Beta (5Y Monthly) 0.904225
PE Ratio (TTM) N/A
EPS (TTM) -20.35 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 856.25 EUR

BUWA.F Valuation Measures

Enterprise Value 9.63B EUR
Trailing P/E N/A
Forward P/E 25.220587
PEG Ratio (5 yr expected) 3.21
Price/Sales (ttm) 3.616814
Price/Book (mrq) 1.0401504
Enterprise Value/Revenue 3.464
Enterprise Value/EBITDA 17.33

Trading Information

Bio-Rad Laboratories, Inc. Stock Price History

Beta (5Y Monthly) 0.904225
52-Week Change -23.90%
S&P500 52-Week Change 20.43%
52 Week High 545.6 EUR
52 Week Low 331 EUR
50-Day Moving Average 385.5 EUR
200-Day Moving Average 412.71 EUR

BUWA.F Share Statistics

Avg. Volume (3 month) 2 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 23.98M
Float 21.09M
Short Ratio N/A
% Held by Insiders 14.52%
% Held by Institutions 79.70%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -6.88%
Operating Margin (ttm) 14.97%
Gross Margin 55.00%
EBITDA Margin 19.98%

Management Effectiveness

Return on Assets (ttm) 1.85%
Return on Equity (ttm) -1.91%

Income Statement

Revenue (ttm) 2.78B EUR
Revenue Per Share (ttm) 93.57 EUR
Quarterly Revenue Growth (yoy) -3.30%
Gross Profit (ttm) 1.57B EUR
EBITDA 555.52M EUR
Net Income Avi to Common (ttm) -191226000 EUR
Diluted EPS (ttm) -6.7
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.85B EUR
Total Cash Per Share (mrq) 62.53 EUR
Total Debt (mrq) 1.38B EUR
Total Debt/Equity (mrq) 14.15 EUR
Current Ratio (mrq) 5.558
Book Value Per Share (mrq) 329.76

Cash Flow Statement

Operating Cash Flow (ttm) 242.02M EUR
Levered Free Cash Flow (ttm) 103.6M EUR

Profile of Bio-Rad Laboratories, Inc.

Country Germany
State CA
City Hercules
Address 1000 Alfred Nobel Drive
ZIP 94547
Phone 510 724 7000
Website https://www.bio-rad.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 8200

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Q&A For Bio-Rad Laboratories, Inc. Stock

What is a current BUWA.F stock price?

Bio-Rad Laboratories, Inc. BUWA.F stock price today per share is 285 EUR.

How to purchase Bio-Rad Laboratories, Inc. stock?

You can buy BUWA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bio-Rad Laboratories, Inc.?

The stock symbol or ticker of Bio-Rad Laboratories, Inc. is BUWA.F.

Which industry does the Bio-Rad Laboratories, Inc. company belong to?

The Bio-Rad Laboratories, Inc. industry is Medical Devices.

How many shares does Bio-Rad Laboratories, Inc. have in circulation?

The max supply of Bio-Rad Laboratories, Inc. shares is 28.66M.

What is Bio-Rad Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?

Bio-Rad Laboratories, Inc. PE Ratio is now.

What was Bio-Rad Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?

Bio-Rad Laboratories, Inc. EPS is -20.35 EUR over the trailing 12 months.

Which sector does the Bio-Rad Laboratories, Inc. company belong to?

The Bio-Rad Laboratories, Inc. sector is Healthcare.